MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT03739801 · WITHDRAWN

Trial details

NCT number: NCT03739801
Sponsor: University of Southern California
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Unresectable Gastric Adenocarcinoma Metastatic Gastroesophageal Junction Adenocarcinoma Metastatic Unresectable Gastric Adenocarcinoma Unresectable Gastroesophageal Junction Adenocarcinoma Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2020-04-06
Primary completion: 2022-04-06
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.